These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 22937056)
1. Variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and prediction of fatal and non-fatal ischemic stroke. Rathcke CN; Thomsen SB; Linneberg A; Vestergaard H PLoS One; 2012; 7(8):e43498. PubMed ID: 22937056 [TBL] [Abstract][Full Text] [Related]
2. Plasma levels of the proinflammatory chitin-binding glycoprotein YKL-40, variation in the chitinase 3-like 1 gene (CHI3L1), and incident cardiovascular events. Ridker PM; Chasman DI; Rose L; Loscalzo J; Elias JA J Am Heart Assoc; 2014 Jun; 3(3):e000897. PubMed ID: 24958781 [TBL] [Abstract][Full Text] [Related]
3. The Association between genetic variations of CHI3L1, levels of the encoded glycoprotein YKL-40 and the lipid profile in a Danish population. Thomsen SB; Rathcke CN; Skaaby T; Linneberg A; Vestergaard H PLoS One; 2012; 7(10):e47094. PubMed ID: 23071724 [TBL] [Abstract][Full Text] [Related]
4. Promoter polymorphisms in the chitinase 3-like 1 gene influence the serum concentration of YKL-40 in Danish patients with rheumatoid arthritis and in healthy subjects. Nielsen KR; Steffensen R; Boegsted M; Baech J; Lundbye-Christensen S; Hetland ML; Krintel SB; Johnsen HE; Nyegaard M; Johansen JS Arthritis Res Ther; 2011 Jun; 13(3):R109. PubMed ID: 21714862 [TBL] [Abstract][Full Text] [Related]
5. Elevated plasma YKL-40, lipids and lipoproteins, and ischemic vascular disease in the general population. Kjaergaard AD; Johansen JS; Bojesen SE; Nordestgaard BG Stroke; 2015 Feb; 46(2):329-35. PubMed ID: 25624368 [TBL] [Abstract][Full Text] [Related]
6. Circulating YKL-40 level, but not CHI3L1 gene variants, is associated with atherosclerosis-related quantitative traits and the risk of peripheral artery disease. Wu S; Hsu LA; Cheng ST; Teng MS; Yeh CH; Sun YC; Huang HL; Ko YL Int J Mol Sci; 2014 Dec; 15(12):22421-37. PubMed ID: 25486056 [TBL] [Abstract][Full Text] [Related]
7. Genetic variation in chitinase 3-like 1 (CHI3L1) contributes to asthma severity and airway expression of YKL-40. Gomez JL; Crisafi GM; Holm CT; Meyers DA; Hawkins GA; Bleecker ER; Jarjour N; ; Cohn L; Chupp GL J Allergy Clin Immunol; 2015 Jul; 136(1):51-58.e10. PubMed ID: 25592985 [TBL] [Abstract][Full Text] [Related]
8. Plasma YKL-40 and CHI3L1 in systemic inflammation and sepsis-experience from two prospective cohorts. Kornblit B; Hellemann D; Munthe-Fog L; Bonde J; Strøm JJ; Madsen HO; Johansen JS; Garred P Immunobiology; 2013 Oct; 218(10):1227-34. PubMed ID: 23706599 [TBL] [Abstract][Full Text] [Related]
9. Genetic polymorphisms in chitinase 3-like 1 (CHI3L1) are associated with circulating YKL-40 levels, but not with angiographic coronary artery disease in a Chinese population. Zheng JL; Lu L; Hu J; Zhang RY; Zhang Q; Chen QJ; Shen WF Cytokine; 2011 Apr; 54(1):51-5. PubMed ID: 21257319 [TBL] [Abstract][Full Text] [Related]
10. Observational and genetic plasma YKL-40 and cancer in 96,099 individuals from the general population. Kjaergaard AD; Nordestgaard BG; Johansen JS; Bojesen SE Int J Cancer; 2015 Dec; 137(11):2696-704. PubMed ID: 26095694 [TBL] [Abstract][Full Text] [Related]
11. A promoter variant in the chitinase 3-like 1 gene is associated with serum YKL-40 level and personality trait. Yamamori H; Hashimoto R; Ohi K; Yasuda Y; Fukumoto M; Kasahara E; Sekiyama A; Umeda-Yano S; Okada T; Iwase M; Kazui H; Ito A; Takeda M Neurosci Lett; 2012 Apr; 513(2):204-8. PubMed ID: 22366530 [TBL] [Abstract][Full Text] [Related]
12. CHI3L1 polymorphisms associate with asthma in a Taiwanese population. Tsai Y; Ko Y; Huang M; Lin M; Wu C; Wang C; Chen Y; Li J; Tseng Y; Wang T BMC Med Genet; 2014 Jul; 15():86. PubMed ID: 25056157 [TBL] [Abstract][Full Text] [Related]
13. Elevated plasma YKL-40 levels and ischemic stroke in the general population. Kjaergaard AD; Bojesen SE; Johansen JS; Nordestgaard BG Ann Neurol; 2010 Nov; 68(5):672-80. PubMed ID: 21031582 [TBL] [Abstract][Full Text] [Related]
14. A CHI3L1 gene polymorphism is associated with serum levels of YKL-40, a novel sarcoidosis marker. Kruit A; Grutters JC; Ruven HJ; van Moorsel CC; van den Bosch JM Respir Med; 2007 Jul; 101(7):1563-71. PubMed ID: 17236752 [TBL] [Abstract][Full Text] [Related]
15. Elevation in circulating YKL-40 concentration in patients with cerebrovascular disease. Xu X; Ma H; Xu J; Huang H; Wu X; Xiong Y; Zhan H; Huang F Bosn J Basic Med Sci; 2014 Aug; 14(3):120-4. PubMed ID: 25172968 [TBL] [Abstract][Full Text] [Related]
16. Association of polymorphisms of the CHI3L1 gene with asthma and atopy: a populations-based study of 6514 Danish adults. Rathcke CN; Holmkvist J; Husmoen LL; Hansen T; Pedersen O; Vestergaard H; Linneberg A PLoS One; 2009 Jul; 4(7):e6106. PubMed ID: 19568425 [TBL] [Abstract][Full Text] [Related]
17. The chitinase-like protein YKL-40: a possible biomarker of inflammation and airway remodeling in severe pediatric asthma. Konradsen JR; James A; Nordlund B; Reinius LE; Söderhäll C; Melén E; Wheelock AM; Lödrup Carlsen KC; Lidegran M; Verhoek M; Boot RG; Dahlén B; Dahlén SE; Hedlin G J Allergy Clin Immunol; 2013 Aug; 132(2):328-35.e5. PubMed ID: 23628340 [TBL] [Abstract][Full Text] [Related]
18. [Association between CHI3L1 SNPs and susceptibility to childhood asthma]. Li JM; Zhang HF; Shen XL; Xie H; Wu XD; Shen T; Wang Y Zhongguo Dang Dai Er Ke Za Zhi; 2015 Feb; 17(2):144-8. PubMed ID: 25760838 [TBL] [Abstract][Full Text] [Related]
19. YKL-40 genetic polymorphisms and the risk of liver disease progression in patients with advanced fibrosis due to chronic hepatitis C. Fontana RJ; Litman HJ; Dienstag JL; Bonkovsky HL; Su G; Sterling RK; Lok AS; Liver Int; 2012 Apr; 32(4):665-74. PubMed ID: 22103814 [TBL] [Abstract][Full Text] [Related]
20. Genetic variants in CHI3L1 influencing YKL-40 levels: resequencing 900 individuals and genotyping 9000 individuals from the general population. Kjaergaard AD; Johansen JS; Nordestgaard BG; Bojesen SE J Med Genet; 2013 Dec; 50(12):831-7. PubMed ID: 24062521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]